Gene Expression Profiling by Microarrays (Hardcover)

Wolf-Karsten Hofmann

ISBN 10: 0521853966 / ISBN 13: 9780521853965

Edité par Cambridge University Press, Cambridge, 2006

A propos de cet article

Hardcover. Microarray analysis is a highly efficient tool for assessing the expression of a large number of genes simultaneously, and offers a new means to classify cancer and other diseases. Gene expression profiling can also be used to predict clinical outcome and response to specific therapeutic agents. This survey spans recent applications of microarrays in clinical medicine, covering malignant disease including acute leukaemias, lymphoid malignancies and breast cancer, together with diabetes and heart disease. Investigators in oncology, pharmacology and related clinical sciences, as well as basic scientists, will value this review of a promising new diagnostic and prognostic technology. Microarray analysis is a highly efficient tool for assessing the expression of a large number of genes simultaneously. This survey spans recent applications of microarrays in clinical medicine, covering malignant disease including acute leukaemias, lymphoid malignancies and breast cancer, together with diabetes and heart disease. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. N° de réf. du vendeur 9780521853965

Détails bibliographiques

Titre : Gene Expression Profiling by Microarrays (...

Éditeur : Cambridge University Press, Cambridge

Date d'édition : 2006

Reliure : Hardcover

Etat : new

Edition : Edition originale

A propos de ce titre

Synopsis :

Book by None

Présentation de l'éditeur:

Microarray analysis is a highly efficient tool for assessing the expression of a large number of genes simultaneously, and offers a new means to classify cancer and other diseases. Gene expression profiling can also be used to predict clinical outcome and response to specific therapeutic agents. This survey spans recent applications of microarrays in clinical medicine, covering malignant disease including acute leukaemias, lymphoid malignancies and breast cancer, together with diabetes and heart disease. Investigators in oncology, pharmacology and related clinical sciences, as well as basic scientists, will value this review of a promising new diagnostic and prognostic technology.